Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

Exclusion Criteria

• •Subject who has a medical history of severe cardiovascular, respiratory, hepatobiliary, renal disease hematologic, gastrointestinal, endocrinological, immunologic, dermatosis or neuropsychologic disease.
• •Subject who have symptoms, result from acute disease within 28days before first administration.
• •Subject who have chronic persisting disease with clinical significance.
• •Subject who fall under the criteria below in laboratory test.
• •* AST/ALT \> UNL (upper normal limit) x 2
• •* Total bilirubin \> UNL x 1.5
• •* In case of renal failure that creatine clearance is less than 50mL/min according to Cockcroft-Gault
• •* CPK \> UNL x 2.5
• •Subject who with low blood pressure with clinical significance at screening test.
• •(systolic blood pressure is less than 90 mmHg and diastolic blood pressure is less than 60 mmHg)
• •Subject with any positive reaction in HBs Ag, anti-HCV Ab, anti-HIV Ab, VDRL tests.